OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
Yi Wang, Kai Conrad Cecil Johnson, Margaret E. Gatti‐Mays, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 90

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 49

Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity
Yongsheng Li, Zhiyong Shen, Zhen Chai, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2307-2320
Open Access | Times Cited: 42

Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
Junli Lu, Yiming Luo, Dean Rao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 31

cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Hongying Zhang, Yongliang Liu, Jieya Liu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 25

Versatile function of NF-ĸB in inflammation and cancer
Qiang Ma, Shuai Hao, Weilong Hong, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 15

Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 1

Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Haowei Sun, Yingmei Li, Peng Zhang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 65

Nanomaterials: Breaking through the bottleneck of tumor immunotherapy
Yue Kang, Shenglong Li
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123159-123159
Closed Access | Times Cited: 33

Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13

Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
Binglei Zhang, Jianxiang Shi, Xiaojing Shi, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101068-101068
Closed Access | Times Cited: 8

Oxidized mRNA Lipid Nanoparticles for In Situ Chimeric Antigen Receptor Monocyte Engineering
Alvin J. Mukalel, Alex G. Hamilton, Margaret M. Billingsley, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 27
Open Access | Times Cited: 7

Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7

Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis
Xinyu Ye, Xin Huang, Xing Fu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 20

Functions and mechanisms of lactylation in carcinogenesis and immunosuppression
Jing Su, Zhuangzhuang Zheng, Chenbin Bian, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20

Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy
Chao Yang, Dan Li, Chung‐Nga Ko, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18

Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy
Jie Li, Huamin Zeng, Luwei Li, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 24593-24618
Closed Access | Times Cited: 18

CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond
Jialin Lu, Yuqing Ma, Q. Quentin Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6

Targeting immune checkpoints on myeloid cells: current status and future directions
Chuhan Ma, Yang Li, Min Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access

The Role of Chronic Inflammation in Pediatric Cancer
Christine Mella, Panogiotis Tsarouhas, Maximillian Brockwell, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 154-154
Open Access

Establish and validate a nomogram prognostic model for young patients with stage IV lung adenocarcinoma
Guo Tian, Yu Li, Lei Cao, et al.
Research Square (Research Square) (2025)
Closed Access

Nanoparticle-based Drug Delivery Systems to Modulate Tumor Immune Response for Glioblastoma Treatment
Yan-Juan Xiong, Maoyuan Sun, Qingzhu Yang, et al.
Acta Biomaterialia (2025)
Closed Access

Exploring Core Genes Associated with Sepsis and Systemic Inflammatory Response Syndrome Using Single-Cell Sequencing Technology
Y. Shen, Liang Leng, Yingchun Hu
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1815-1838
Open Access

Page 1 - Next Page

Scroll to top